Eva‐María Priego

1.5k total citations
51 papers, 1.3k citations indexed

About

Eva‐María Priego is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Eva‐María Priego has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Eva‐María Priego's work include Biochemical and Molecular Research (11 papers), Synthesis and biological activity (8 papers) and Mosquito-borne diseases and control (7 papers). Eva‐María Priego is often cited by papers focused on Biochemical and Molecular Research (11 papers), Synthesis and biological activity (8 papers) and Mosquito-borne diseases and control (7 papers). Eva‐María Priego collaborates with scholars based in Spain, Belgium and United Kingdom. Eva‐María Priego's co-authors include María‐Jesús Pérez‐Pérez, Marı́a-José Camarasa, Sandra Liekens, Nazario Martı́n, Jan Balzarini, Ana Isabel Hernández, José L. Segura, Dirk M. Guldi, Leen Delang and Chuping Luo and has published in prestigious journals such as Biochemistry, Cancer Research and Langmuir.

In The Last Decade

Eva‐María Priego

49 papers receiving 1.3k citations

Peers

Countries citing papers authored by Eva‐María Priego

Since Specialization

Citations

This map shows the geographic impact of Eva‐María Priego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva‐María Priego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva‐María Priego more than expected).

Fields of papers citing papers by Eva‐María Priego

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva‐María Priego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva‐María Priego. The network helps show where Eva‐María Priego may publish in the future.

Co-authorship network of co-authors of Eva‐María Priego

This figure shows the co-authorship network connecting the top 25 collaborators of Eva‐María Priego. A scholar is included among the top collaborators of Eva‐María Priego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva‐María Priego. Eva‐María Priego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neutral sphingomyelinase 2 inhibition alters inflammatory gene expression signatures in the brain of mice infected with West Nile virus 2025 ·International Immunopharmacology ·(unknown), (unknown), Ana-Belén Blázquez, (unknown), Estela Escribano-Romero, Nereida Jiménez de Oya, Eva Calvo-Pinilla, María‐Jesús Pérez‐Pérez, Eva‐María Priego, Miguel A. Martín-Acebes	0
2	Lipid-targeting antiviral strategies: Current state and future perspectives 2025 ·Antiviral Research ·Ana-Belén Blázquez, (unknown), Ernesto Quesada, Eva‐María Priego, María‐Jesús Pérez‐Pérez, Miguel A. Martín-Acebes	3
3	Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), Ana-Belén Blázquez, (unknown), Juan‐Carlos Sáiz, María‐Jesús Pérez‐Pérez, Miguel A. Martín-Acebes, Eva‐María Priego	4
4	Chikungunya virus drug discovery: still a long way to go? 2019 ·Expert Opinion on Drug Discovery ·María‐Jesús Pérez‐Pérez, Leen Delang, Lisa F. P. Ng, Eva‐María Priego	26
5	High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design 2018 ·Scientific Reports ·(unknown), Juan Estévez‐Gallego, (unknown), A.E. Prota, Federico Gago, Asier Gómez‐SanJuan, Marı́a-José Camarasa, Isabel Barasoaı́n, Michel O. Steinmetz, J. Fernando Dı́az, María‐Jesús Pérez‐Pérez, Sandra Liekens, Eva‐María Priego	43
6	Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation 2018 ·Scientific Reports ·Alicia Bort, (unknown), (unknown), (unknown), Eva‐María Priego, (unknown), (unknown), Jose Gasalla-Herraiz, Nieves Rodríguez‐Henche, Ana Castro, Inés Dı́az-Laviada	21
7	Conformational mimetics of the α-methyl chalcone TUB091 binding tubulin: Design, synthesis and antiproliferative activity 2018 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Ernesto Quesada, Juan Estévez‐Gallego, Sam Noppen, Marı́a-José Camarasa, J. Fernando Dı́az, Sandra Liekens, Eva‐María Priego, María‐Jesús Pérez‐Pérez	14
8	Antiviral activity of [1,2,3]triazolo[4,5- d ]pyrimidin-7(6 H )-ones against chikungunya virus targeting the viral capping nsP1 2017 ·Antiviral Research ·Alba Gigante, Asier Gómez‐SanJuan, Leen Delang, (unknown), (unknown), (unknown), Eva‐María Priego, Marı́a-José Camarasa, Dirk Jochmans, Pieter Leyssen, Étienne Decroly, Bruno Coutard, Gilles Quérat, Johan Neyts, María‐Jesús Pérez‐Pérez	42
9	Synthesis and antiproliferative activity of 6-phenylaminopurines 2014 ·European Journal of Medicinal Chemistry ·(unknown), Sandra Liekens, Marı́a-José Camarasa, Eva‐María Priego, María‐Jesús Pérez‐Pérez	9
10	Targeting LMO2 with a Peptide Aptamer Establishes a Necessary Function in Overt T-Cell Neoplasia 2009 ·Cancer Research ·Alex Appert, Chang‐Hoon Nam, (unknown), Eva‐María Priego, Ricardo Núñez Miguel, Tom L. Blundell, Lesley Drynan, (unknown), Tomoyuki Tanaka, Terence H. Rabbitts	36
11	Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): Present and future 2008 ·Medicinal Research Reviews ·María‐Jesús Pérez‐Pérez, Eva‐María Priego, Ana Isabel Hernández, (unknown), Marı́a-José Camarasa, Ana Negri, Federico Gago, Jan Balzarini	19
12	Synthesis and radical coupling of pyridine-bridged π-extended tetrathiafulvalene (TTF)-type donors and push–pull analogues 2007 ·Organic & Biomolecular Chemistry ·Eva‐María Priego, Luis Sánchez, M. Ángeles Herranz, Nazario Martı́n, Rafael Viruela, Enrique Ortı́	12
13	Selective Human Adenosine A₃ Antagonists based on Pyrido[2,1‐f]purine‐2,4‐diones: Novel Features of hA₃ Antagonist Binding 2007 ·ChemMedChem ·Eva‐María Priego, María‐Jesús Pérez‐Pérez, (unknown), Henk de Vries, Adriaan P. IJzerman, Marı́a-José Camarasa, Sonsoles Martín‐Santamaría	12
14	Genome bioinformatic analysis of nonsynonymous SNPs 2007 ·BMC Bioinformatics ·David F. Burke, Catherine L. Worth, Eva‐María Priego, Tammy M. K. Cheng, Luc J Smink, John A. Todd, Tom L. Blundell	38
15	5‘-O-Tritylinosine and Analogues as Allosteric Inhibitors of Human Thymidine Phosphorylase 2006 ·Journal of Medicinal Chemistry ·Elena Casanova, Ana Isabel Hernández, Eva‐María Priego, Sandra Liekens, Marı́a-José Camarasa, Jan Balzarini, María‐Jesús Pérez‐Pérez	34
16	Mitochondrial Thymidine Kinase Inhibitors 2005 ·Current Topics in Medicinal Chemistry ·María‐Jesús Pérez‐Pérez, Ana Isabel Hernández, Eva‐María Priego, Fátima Rodrı́guez-Barrios, Federico Gago, Marı́a-José Camarasa, Jan Balzarini	11
17	Thymidine Phosphorylase Inhibitors: Recent Developments and Potential Therapeutic Applications 2005 ·Mini-Reviews in Medicinal Chemistry ·María‐Jesús Pérez‐Pérez, Eva‐María Priego, Ana Isabel Hernández, Marı́a-José Camarasa, Jan Balzarini, Sandra Liekens	55
18	Synthesis and evaluation of thymine-derived carboxamides against mitochondrial thymidine kinase (TK-2) and related enzymes 2004 ·Bioorganic & Medicinal Chemistry ·Eva‐María Priego, Jan Balzarini, Anna Karlsson, Marı́a-José Camarasa, María‐Jesús Pérez‐Pérez	9
19	Towards New Thymidine Phosphorylase/PD-ECGF Inhibitors Based on the Transition State of the Enzyme Reaction 2003 ·Nucleosides Nucleotides & Nucleic Acids ·Eva‐María Priego, Jesús Mendieta, Federico Gago, Jan Balzarini, Erik De Clercq, Marı́a-José Camarasa, María‐Jesús Pérez‐Pérez	2
20	Anti‐angiogenic activity of a novel multi‐substrate analogue inhibitor of thymidine phosphorylase 2001 ·FEBS Letters ·Sandra Liekens, (unknown), Erik De Clercq, Eva‐María Priego, Marı́a-José Camarasa, María‐Jesús Pérez‐Pérez, Jan Balzarini	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact